Clinical trials
Diabetes Mellitus trials in Israel with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 3 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Unknown status | 15 |
| Terminated | 3 |
| Not yet recruiting | 2 |
| Recruiting | 2 |
| Suspended | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sheba Medical Center | 6 |
| Assaf-Harofeh Medical Center | 4 |
| Hadassah Medical Organization | 3 |
| Medtronic MiniMed, Inc. | 3 |
| Rabin Medical Center | 3 |
| HaEmek Medical Center, Israel | 2 |
| Insuline Medical Ltd. | 2 |
| Meir Medical Center | 2 |
| NiliMedix | 2 |
| Antea Foundation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus | 43 |
| Diabetes Mellitus, Type 1 | 5 |
| Diabetes Mellitus, Type 2 | 5 |
| Obesity | 4 |
| Hyperglycemia | 3 |
| Diabetes, Gestational | 2 |
| Glucose Intolerance | 2 |
| Metabolic Syndrome | 2 |
| Atherosclerosis | 1 |
| Cardiovascular Diseases | 1 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.